IL-17R–EGFR axis links wound healing to tumorigenesis in Lrig1 + stem cells

86Citations
Citations of this article
69Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Lrig1 marks a distinct population of stem cells restricted to the upper pilosebaceous unit in normal epidermis. Here we report that IL-17A–mediated activation of EGFR plays a critical role in the expansion and migration of Lrig1 + stem cells and their progenies in response to wounding, thereby promoting wound healing and skin tumorigenesis. Lrig1-specific deletion of the IL-17R adaptor Act1 or EGFR in mice impairs wound healing and reduces tumor formation. Mechanistically, IL-17R recruits EGFR for IL-17A–mediated signaling in Lrig1 + stem cells. While TRAF4, enriched in Lrig1 + stem cells, tethers IL-17RA and EGFR, Act1 recruits c-Src for IL-17A–induced EGFR transactivation and downstream activation of ERK5, which promotes the expansion and migration of Lrig1 + stem cells. This study demonstrates that IL-17A activates the IL-17R–EGFR axis in Lrig1 + stem cells linking wound healing to tumorigenesis.

Cite

CITATION STYLE

APA

Chen, X., Cai, G., Liu, C., Zhao, J., Gu, C., Wu, L., … Li, X. (2019). IL-17R–EGFR axis links wound healing to tumorigenesis in Lrig1 + stem cells. Journal of Experimental Medicine, 216(1), 195–214. https://doi.org/10.1084/jem.20171849

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free